Bazell Pharma

Amzell is a specialized virtual pharmaceutical development company founded in 2016. The company specializes in advancing well-characterized pharmaceuticals, utilizing innovative drug delivery technologies for enhanced efficacy, safety, and compliance. Amzell focuses on developing well-characterized active substances using innovative platform drug delivery technologies, leading to more effective drug delivery, increased efficacy, and improved safety and compliance. The company operates in the Health Care and Pharmaceutical industries. Amzell BV's unique focus on advancing candidate or re-purposed drugs and devices from proof of concept to registration for sale to commercial healthcare companies sets it apart in the pharmaceutical development landscape. The innovative drug delivery technologies it employs are designed to enhance the efficacy, safety, and compliance of pharmaceuticals, presenting a promising value proposition in the market. As of now, there is no publicly available information regarding the last investment or the investors involved in Amzell BV. However, given the innovative and specialized nature of the company's work, it presents an intriguing potential investment opportunity for venture capitalists interested in the healthcare and pharmaceutical sectors. With a strong emphasis on technological advancement in drug delivery and a focus on addressing critical industry needs, Amzell BV demonstrates considerable potential for growth and impact within the healthcare landscape.